Ontology highlight
ABSTRACT:
SUBMITTER: Oyekunle AA
PROVIDER: S-EPMC4575984 | biostudies-other | 2015
REPOSITORIES: biostudies-other
Oyekunle Anthony A AA Bolarinwa Rahman A RA Oyelese Adesola T AT Salawu Lateef L Durosinmi Muheez A MA
Advances in hematology 20150907
Objective. The tyrosine kinase inhibitors have markedly changed the disease course for patients with Ph(+) and/or BCR-ABL1 (+) chronic myeloid leukemia (CML). This study was embarked upon to assess the long-term effects of imatinib therapy on survival in adult Nigerian patients with CML. Methods. All adult patients on imatinib (400-600 mg) seen from July 2003 to December 2010 were assessed. Male/female distribution was 171/101, with a median age of 38 (range, 20-75) years. Overall survival (OS) ...[more]